Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,465 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I/II study of FOLFIRI in Japanese patients with advanced colorectal cancer.
Yamashita K, Nagashima F, Fujita K, Yamamoto W, Endo H, Miya T, Narabayashi M, Kawara K, Akiyama Y, Ando Y, Ando M, Sasaki Y. Yamashita K, et al. Among authors: ando y, ando m. Jpn J Clin Oncol. 2011 Feb;41(2):204-9. doi: 10.1093/jjco/hyq197. Epub 2010 Oct 21. Jpn J Clin Oncol. 2011. PMID: 20965940 Clinical Trial.
Long-term quality of life after laparoscopic distal gastrectomy for early gastric cancer: results of a prospective multi-institutional comparative trial.
Misawa K, Fujiwara M, Ando M, Ito S, Mochizuki Y, Ito Y, Onishi E, Ishigure K, Morioka Y, Takase T, Watanabe T, Yamamura Y, Morita S, Kodera Y. Misawa K, et al. Among authors: ando m. Gastric Cancer. 2015 Apr;18(2):417-25. doi: 10.1007/s10120-014-0374-y. Epub 2014 May 7. Gastric Cancer. 2015. PMID: 24801197 Clinical Trial.
Changes in exercise capacity, muscle strength, and health-related quality of life in esophageal cancer patients undergoing esophagectomy.
Inoue T, Ito S, Ando M, Nagaya M, Aso H, Mizuno Y, Hattori K, Nakajima H, Nishida Y, Niwa Y, Kodera Y, Koike M, Hasegawa Y. Inoue T, et al. Among authors: ando m. BMC Sports Sci Med Rehabil. 2016 Nov 3;8:34. doi: 10.1186/s13102-016-0060-y. eCollection 2016. BMC Sports Sci Med Rehabil. 2016. PMID: 27822378 Free PMC article.
Multi-institutional prospective feasibility study to explore tolerability and efficacy of oral nutritional supplements for patients with gastric cancer undergoing gastrectomy (CCOG1301).
Kobayashi D, Ishigure K, Mochizuki Y, Nakayama H, Sakai M, Ito S, Kojima H, Kajikawa M, Ando M, Kodera Y. Kobayashi D, et al. Among authors: ando m. Gastric Cancer. 2017 Jul;20(4):718-727. doi: 10.1007/s10120-016-0668-3. Epub 2016 Nov 24. Gastric Cancer. 2017. PMID: 27885538 Clinical Trial.
Efficacy of Prophylactic Treatment for Oxycodone-Induced Nausea and Vomiting Among Patients with Cancer Pain (POINT): A Randomized, Placebo-Controlled, Double-Blind Trial.
Tsukuura H, Miyazaki M, Morita T, Sugishita M, Kato H, Murasaki Y, Gyawali B, Kubo Y, Ando M, Kondo M, Yamada K, Hasegawa Y, Ando Y. Tsukuura H, et al. Among authors: ando y, ando m. Oncologist. 2018 Mar;23(3):367-374. doi: 10.1634/theoncologist.2017-0225. Epub 2017 Oct 16. Oncologist. 2018. PMID: 29038236 Free PMC article. Clinical Trial.
Patients With Antithyroid Antibodies Are Prone To Develop Destructive Thyroiditis by Nivolumab: A Prospective Study.
Kobayashi T, Iwama S, Yasuda Y, Okada N, Tsunekawa T, Onoue T, Takagi H, Hagiwara D, Ito Y, Morishita Y, Goto M, Suga H, Banno R, Yokota K, Hase T, Morise M, Hashimoto N, Ando M, Kiyoi H, Gotoh M, Ando Y, Akiyama M, Hasegawa Y, Arima H. Kobayashi T, et al. Among authors: ando y, ando m. J Endocr Soc. 2018 Feb 6;2(3):241-251. doi: 10.1210/js.2017-00432. eCollection 2018 Mar 1. J Endocr Soc. 2018. PMID: 29600292 Free PMC article.
Anti-thyroid antibodies and thyroid echo pattern at baseline as risk factors for thyroid dysfunction induced by anti-programmed cell death-1 antibodies: a prospective study.
Okada N, Iwama S, Okuji T, Kobayashi T, Yasuda Y, Wada E, Onoue T, Goto M, Sugiyama M, Tsunekawa T, Takagi H, Hagiwara D, Ito Y, Suga H, Banno R, Hase T, Morise M, Kanda M, Yokota K, Hashimoto N, Ando M, Fujimoto Y, Nagino M, Kodera Y, Fujishiro M, Hibi H, Sone M, Kiyoi H, Gotoh M, Ando Y, Akiyama M, Hasegawa Y, Arima H. Okada N, et al. Among authors: ando y, ando m. Br J Cancer. 2020 Mar;122(6):771-777. doi: 10.1038/s41416-020-0736-7. Epub 2020 Feb 3. Br J Cancer. 2020. PMID: 32009131 Free PMC article.
Phase II multi-institutional prospective trial of nab-paclitaxel as second-line chemotherapy for advanced gastric cancer refractory to fluoropyrimidine with modified dose reduction criteria (CCOG1303).
Kobayashi D, Mochizuki Y, Torii K, Takeda S, Kawase Y, Ishigure K, Teramoto H, Ando M, Kodera Y. Kobayashi D, et al. Among authors: ando m. Int J Clin Oncol. 2020 Oct;25(10):1793-1799. doi: 10.1007/s10147-020-01724-8. Epub 2020 Jun 21. Int J Clin Oncol. 2020. PMID: 32567012 Clinical Trial.
3,465 results